SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jonna Maaria Jokisalo, Kevin Thomas Trent Corley, CPR in the Neonatal Foal, Veterinary Clinics of North America: Equine Practice, 2014, 30, 2, 301

    CrossRef

  2. 2
    Benedict M. Glover, Xudong Hu, Theresa Aves, Andrew Ramadeen, Lily Zou, Howard Leong-Poi, Hiroko Fujii, Paul Dorian, Dronedarone and Captisol-enabled Amiodarone in an Experimental Cardiac Arrest, Journal of Cardiovascular Pharmacology, 2013, 61, 5, 385

    CrossRef

  3. 3
    Zhongwei Cheng, Mintu Turakhia, Ronald Lo, Anurag Gupta, Paul C. Zei, Henry H. Hsia, Amin Al-Ahmad, Paul J. Wang, Incidence and clinical predictors of low defibrillation safety margin at time of implantable defibrillator implantation, Journal of Interventional Cardiac Electrophysiology, 2012, 34, 1, 93

    CrossRef

  4. You have free access to this content4
    Elizabeth A. Rozanski, John E. Rush, Gareth J. Buckley, Daniel J. Fletcher, Manuel Boller, RECOVER evidence and knowledge gap analysis on veterinary CPR. Part 4: Advanced life support, Journal of Veterinary Emergency and Critical Care, 2012, 22, s1
  5. 5
    Philippe Chevalier, Alexis Durand Dubieff, Eric Piqueras, Julien Pineau, Léna Rivard, Elodie Morel, Bernard Bui-xan, Quadiri Timour, The Impact of Acute Myocardial Ischemia on the Ventricular Defibrillation Threshold During Chronic Oral Azimilide Therapy, Journal of Cardiovascular Pharmacology, 2007, 50, 6, 629

    CrossRef

  6. 6
    MARK W. KROLL, PATRICK J. TCHOU, Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy, 2007,

    CrossRef

  7. 7
    P. Kovoor, A. Love, J. Hall, R. Kruit, N. Sadick, D. Ho, B.-A. Adelstein, D. L. Ross, Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia, Internal Medicine Journal, 2005, 35, 9
  8. 8
    Eleftheria P Tsagalou, Maria I Anastasiou-Nana, Christos E Charitos, Costantinos X Siafakas, Stavros G Drakos, Argirios Ntalianis, John V Terrovitis, Emmanuel M Mavrikakis, Antonios Doufas, John N Nanas, Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone—an experimental study, Resuscitation, 2004, 61, 1, 83

    CrossRef

  9. 9
    Jason Stoner, Gerard Martin, Kevin O'Mara, Joseph Ehlers, Michael Tomlanovich, Amiodarone and Bretylium in the Treatment of Hypothermic Ventricular Fibrillation in a Canine Model, Academic Emergency Medicine, 2003, 10, 3, 187

    CrossRef

  10. 10
    Yadavendra S. Rajawat, Darryl Dias, Edward P. Gerstenfeld, Sanjay Dixit, Bindi Shah, Andrea M. Russo, Francis E. Marchlinski, Interactions of antiarrhythmic drugs and implantable devices in controlling ventricular tachycardia and fibrillation, Current Cardiology Reports, 2002, 4, 5, 434

    CrossRef

  11. 11
    PAUL DORIAN, Amiodarone and Defibrillation Thresholds:, Journal of Cardiovascular Electrophysiology, 2000, 11, 7
  12. 12
    Richard L Page, Effects of antiarrhythmic medication on implantable cardioverter-defibrillator function, The American Journal of Cardiology, 2000, 85, 12, 1481

    CrossRef

  13. 13
    Stephan Windecker, Raymond E Ideker, Vance J Plumb, G.Neal Kay, Gregory P Walcott, Andrew E Epstein, The influence of ventricular fibrillation duration on defibrillation efficacy using biphasic waveforms in humans, Journal of the American College of Cardiology, 1999, 33, 1, 33

    CrossRef

  14. 14
    Li Zhou, Bonnie P Chen, Jeffrey Kluger, Chengde Fan, Moses S.S Chow, Effects of Amiodarone and Its Active Metabolite Desethylamiodarone on the Ventricular Defibrillation Threshold, Journal of the American College of Cardiology, 1998, 31, 7, 1672

    CrossRef

  15. 15
    Colin Movsowitz, Francis E. Marchlinski, Interactions between implantable cardioverter-defibrillators and class III agents, The American Journal of Cardiology, 1998, 82, 4, 41I

    CrossRef

  16. 16
    Steffen Behrens, Cuilan Li, Michael R. &NA;, Effects of Long-Term Amiodarone Treatment on Ventricular-Fibrillation Vulnerability and Defibrillation Efficacy in Response to Monophasic and Biphasic Shocks, Journal of Cardiovascular Pharmacology, 1997, 30, 4, 412

    CrossRef

  17. 17
    SUSAN E. BRODE, DAVID SCHWARTZMAN, DAVID J. CALLANS, CHARLES D. GOTTLIEB, FRANCIS E. MARCHLINSKI, ICD-Antiarrhythmic Drug and ICD-Pacemaker Interactions, Journal of Cardiovascular Electrophysiology, 1997, 8, 7
  18. 18
    ROBERT J. SWEENEY, ROBERT M. GILL, MITCHELL I. STEINBERG, PHILIP R. REID, Effects of Flecainide, Encainide, and Clofilium on Ventricular Refractory Period Extension by Transcardiac Shocks, Pacing and Clinical Electrophysiology, 1996, 19, 1
  19. 19
    H Leon Greene, Interactions Between Pharmacologic and Nonpharmacologic Antiarrhythmic Therapy, The American Journal of Cardiology, 1996, 78, 4, 61

    CrossRef

  20. 20
    DOUGLAS E. KOPP, BRADFORD P. BLAKEMAN, JOHN G. KALL, BRIAN OLSHANSKY, CHARLES A. KINDER, DAVID J. WILBER, Predictors of Defibrillation Energy Requirements with Nonepicardial Lead Systems, Pacing and Clinical Electrophysiology, 1995, 18, 2
  21. 21
    Raymond Yee, George J. Klein, Ranjan K. Thakur, Clinical predictors of successful implantable cardioverter defibrillator implantation, American Heart Journal, 1994, 127, 4, 1068

    CrossRef

  22. 22
    Matthias Manz, Werner Jung, Berndt Lüderitz, Interactions between drugs and devices: Experimental and clinical studies, American Heart Journal, 1994, 127, 4, 978

    CrossRef

  23. 23
    RUSSELL E. HILLSLEY, J. MARCUS WHARTON, ADAM W. CATES, PATRICK D. WOLF, RAYMOND E. IDEKER, Why Do Some Patients Have High Defibrillation Thresholds at Defibrillator Implantation?, Pacing and Clinical Electrophysiology, 1994, 17, 2
  24. 24
    STANLEY NATTEL, MARIO TALAJIC, BERNARD FERMINI, DENIS ROY, Amiodarone: Pharmacology, Clinical Actions, and Relationships Between Them, Journal of Cardiovascular Electrophysiology, 1992, 3, 3
  25. 25
    ERIC N. PRYSTOWSKY, Antiarrhythmic Drug Therapy as an Adjunct or Alternative to An Implantable Cardioverter Defibrillator, Pacing and Clinical Electrophysiology, 1992, 15, 4
  26. 26
    Werner Peters, Eli S. Gang, Hidetaka Okazaki, Simon Solingen, Yoshinori Kobayashi, Hrayr S. Karagueuzian, William J. Mandel, Acute effects of intravenous propafenone on the internal ventricular defibrillation threshold in the anesthetized dog, American Heart Journal, 1991, 122, 5, 1355

    CrossRef

  27. 27
    Sergio L. Pinski, Gabriel Vanerio, Lon W. Castle, Victor A. Morant, Tony W. Simmons, Richard G. Trohman, Bruce L. Wilcoff, James D. Maloney, Patients with a high defibrillation threshold: Clinical characteristics, management, and outcome, American Heart Journal, 1991, 122, 1, 89

    CrossRef